Medical Regulation

Medical regulation is not merely a restriction on what practitioners may do. It serves as a baseline safeguard for protecting the rights and interests of patients and for maintaining order in the medical market.

Its purpose is to prevent or detect conduct such as illegal treatment, false advertising, unlicensed procedures, and the provision of rebates, and in doing so to encourage medical institutions and practitioners to earn the trust of the public.

These cases involve a person who is not a licensed practitioner performing a medical act, or a licensed practitioner providing treatment beyond the scope of his or her license.

Such conduct violates Article 27 of the Medical Service Act and may lead to sanctions that include criminal penalties and suspension of license.

Article 56 of the Medical Service Act tightly limits who may advertise medical services and the content and method of such advertising, so that advertisements likely to mislead consumers can be blocked before they appear.

Showing procedure scenes directly, omitting disclosure of side effects, and misstating academic background or career may draw criminal penalties and administrative dispositions.

Accepting money, goods, or entertainment from a pharmaceutical or medical device company, or receiving anything of value on the condition of prescribing a particular product, constitutes a rebate.

Such conduct can draw severe sanctions as a violation of the Medical Service Act and the Pharmaceutical Affairs Act.

A medical device is an instrument, apparatus, or piece of software used to diagnose, treat, or prevent disease or to correct bodily functions, and it falls under the Medical Devices Act.

Under that Act, requirements such as approval, reporting, and post-market management apply throughout manufacturing, importing, advertising, and sales in order to help ensure safety and effectiveness.

When a procedure or device that has not undergone new health technology assessment is used on a patient, that medical act is generally treated as illegal.

To pass new health technology assessment, the applicant must show through supporting literature that the technology offers safety and effectiveness equal to or greater than that of technologies already in use.

Medical institutions and related companies should track amendments to key statutes such as the Medical Service Act, the Pharmaceutical Affairs Act, and the Medical Devices Act, and conduct regular internal compliance reviews.

In areas where regulation arises often, it helps to understand the governing rules accurately and to put in place procedures and documentation that fit them.

When internal procedures and records reflecting policy standards are prepared before any violation occurs, they can later serve as favorable evidence if a legal dispute arises.

On receiving notice of an investigation or inquiry from a regulatory agency, an institution should promptly gather the key documents that can establish the facts, such as medical records, contracts, and advertising materials.

Caution is warranted, because destroying or partially omitting materials on one's own initiative may be read as destruction of evidence or as intentional conduct.

A sound approach is to designate an internal reporting line and a person responsible for the response, and to set up a system for managing records.

From the earliest stage of an inquiry by agencies such as the Ministry of Health and Welfare, the Ministry of Food and Drug Safety, the Health Insurance Review and Assessment Service, and the National Health Insurance Service, care should be taken with statements and with the documents submitted.

When responding to an investigation, a measured approach is advisable, since the materials provided and the content of statements can weigh heavily on whether a disposition is ultimately imposed.

Because the outcome may turn on how the early stage is handled, careful preparation is warranted.

Where a disposition has already become final, relief may be sought through an administrative appeal or administrative litigation, and that process typically contests both the legal validity of the disposition and any procedural unlawfulness.

Rather than simply arguing that the disposition is excessive, it is often more effective to organize the established facts and the questions of statutory interpretation in a clear, logical way.

Assembling medical records, expert opinions, and internal guidelines into supporting materials that a court can accept is a central part of this strategy.

When an investigative agency such as the prosecution or the police is involved, the defense should center on the factors that drive a finding of unlawfulness, including the presence of intent or negligence, the legitimacy of the medical act, and the measures taken to protect the patient.

Rather than a blanket denial, an explanation grounded in objective facts and clinical judgment can support meaningful mitigation or a decision not to indict.

Careful preparation before giving a statement is advisable, and it should be kept in mind that all statements and submitted materials can have a significant effect on the legal outcome.

To reduce recurring regulatory risk, medical institutions and companies may find it useful to organize internal rules by field and to run regular training for the staff responsible.

Setting up prior review procedures and self-screening systems for each high-risk area, such as medical advertising, rebates, and clinical trials, can make a real difference.

Rather than reacting after an incident, a structural system that lowers the chance of problems in the first place is often the key to long-term legal stability.